Dr. Bastian, with 30+ years of global leadership experience at leading life sciences and healthcare companies, joins iXCells, bringing extensive knowledge from technology-driven companies such as M2GEN (now Aster Insights), Thermo Fisher Scientific, Indivumed, Sigma-Aldrich (now part of Merck KGaA), SGS and QIAGEN. Currently a Board Member for Molecular Assemblies (San Diego) and Strategic Advisor for PreComb Therapeutics (Switzerland), he also advised startups in the USA and Europe, advancing next-gen sequencing and molecular diagnostics. Holding a Ph.D. from the Max Planck Institute for Biophysical Chemistry, Goettingen, Germany; an alumnus from Columbia Business School, NY.
in